Job Postings

BioVectra Inc. is a leading bioscience business located in Prince Edward Island and Nova Scotia, focused on contract manufacturing and product development of active pharmaceutical ingredients, pharmaceutical intermediates, and bio-reagents. BioVectra is an industry leader in microbial fermentation, with 64,000 L of fermentation capacity.

FIGR is PEI’s only licensed cannabis producer located in the Charlottetown BioCommons Research Park. FIGR produces, processes and distributes cannabis-based products for the adult-recreational and medicinal cannabis markets. The facility is comprised of 24,000 square feet with two floors dedicated to growing and processing recreational and medical cannabis – with an expansion currently in the works.

Elanco Canada Ltd. is the animal health division of Eli Lily and Company. On PEI, the biotech pharmaceutical company manufactures vaccines for fish for customers from all over the world. PEI is home to a large manufacturing facility and Elanco’s Aquaculture R & D division.

Sekisui Diagnostics P.E.I. Inc. is a global leading manufacturer and developer of in-vitro diagnostics products, focused on bringing general and specialty clinical chemistry reagents to diagnostics manufacturers and clinical laboratories worldwide. Based in Japan, the company purchased an existing bioscience company in Charlottetown which each year, produces 1.5 billion clinical chemistry tests in P.E.I. that are then shipped around the world. Sekisui was named one of Canada’s top 100 Employers in 2018.

Sekisui Diagnostics P.E.I. Inc. is a global leading manufacturer and developer of in-vitro diagnostics products, focused on bringing general and specialty clinical chemistry reagents to diagnostics manufacturers and clinical laboratories worldwide. Based in Japan, the company purchased an existing bioscience company in Charlottetown which each year, produces 1.5 billion clinical chemistry tests in P.E.I. that are then shipped around the world. Sekisui was named one of Canada’s top 100 Employers in 2018.

Sekisui Diagnostics P.E.I. Inc. is a global leading manufacturer and developer of in-vitro diagnostics products, focused on bringing general and specialty clinical chemistry reagents to diagnostics manufacturers and clinical laboratories worldwide. Based in Japan, the company purchased an existing bioscience company in Charlottetown which each year, produces 1.5 billion clinical chemistry tests in P.E.I. that are then shipped around the world. Sekisui was named one of Canada’s top 100 Employers in 2018.

Sekisui Diagnostics P.E.I. Inc. is a global leading manufacturer and developer of in-vitro diagnostics products, focused on bringing general and specialty clinical chemistry reagents to diagnostics manufacturers and clinical laboratories worldwide. Based in Japan, the company purchased an existing bioscience company in Charlottetown which each year, produces 1.5 billion clinical chemistry tests in P.E.I. that are then shipped around the world. Sekisui was named one of Canada’s top 100 Employers in 2018.

Sekisui Diagnostics P.E.I. Inc. is a global leading manufacturer and developer of in-vitro diagnostics products, focused on bringing general and specialty clinical chemistry reagents to diagnostics manufacturers and clinical laboratories worldwide. Based in Japan, the company purchased an existing bioscience company in Charlottetown which each year, produces 1.5 billion clinical chemistry tests in P.E.I. that are then shipped around the world. Sekisui was named one of Canada’s top 100 Employers in 2018.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.